Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 175.00p on 07-10-2025 at 18:30:05
Change 0.00p 0%
Buy 180.00p
Sell 170.00p
Last Trade: Unknown 27,000.00 at 175.00p
Day's Volume: 71,148
Last Close: 175.00p
Open: 180.00p
ISIN: FI4000153309
Day's Range 175.00p - 175.00p
52wk Range: 142.50p - 265.00p
Market Capitalisation: £195.92m
VWAP: 173.16915p
Shares in Issue: 111.95m

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 27,000 175.00p Uncrossing Trade
16:35:18 - 07-Oct-25
Sell* 83 171.60p Ordinary
16:11:38 - 07-Oct-25
Buy* 193 178.50p Ordinary
15:22:46 - 07-Oct-25
Sell* 238 171.60p Ordinary
14:57:42 - 07-Oct-25
Buy* 420 178.50p Ordinary
14:41:55 - 07-Oct-25
Buy* 53 178.50p Ordinary
14:07:51 - 07-Oct-25
Buy* 300 178.90p Ordinary
13:11:41 - 07-Oct-25
Buy* 1,679 177.90p Ordinary
13:09:33 - 07-Oct-25
Sell* 2,926 171.30p Ordinary
12:52:33 - 07-Oct-25
Sell* 1,000 171.30p Ordinary
12:50:24 - 07-Oct-25
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
7th Oct 2025 (Tue) 180.00 175.00 175.00 175.00 71,148
6th Oct 2025 (Mon) 182.50 175.00 175.00 175.00 69,365
3rd Oct 2025 (Fri) 185.00 185.00 180.00 182.50 7,506
2nd Oct 2025 (Thu) 180.00 185.00 180.00 185.00 22,638
1st Oct 2025 (Wed) 180.00 180.00 175.00 180.00 253,619
30th Sep 2025 (Tue) 180.00 180.00 175.00 180.00 74,495
29th Sep 2025 (Mon) 185.00 175.00 175.00 175.00 198,682
26th Sep 2025 (Fri) 187.50 185.00 180.00 185.00 6,415
25th Sep 2025 (Thu) 187.50 187.50 180.00 187.50 4,081
24th Sep 2025 (Wed) 190.00 190.00 187.50 187.50 8,192
23rd Sep 2025 (Tue) 187.50 190.00 187.50 190.00 6,860
22nd Sep 2025 (Mon) 187.50 190.00 187.50 187.50 2,212
19th Sep 2025 (Fri) 187.50 187.50 187.50 187.50 1,587
18th Sep 2025 (Thu) 180.00 187.50 180.00 187.50 12,592
17th Sep 2025 (Wed) 187.50 187.50 185.00 185.00 8,255
16th Sep 2025 (Tue) 187.50 187.50 187.50 187.50 2,045
15th Sep 2025 (Mon) 185.00 187.50 185.00 187.50 20,083
12th Sep 2025 (Fri) 185.00 185.00 185.00 185.00 3,244
11th Sep 2025 (Thu) 187.50 187.50 182.50 185.00 35,133
10th Sep 2025 (Wed) 192.50 192.50 187.50 187.50 9,771
9th Sep 2025 (Tue) 195.00 195.00 192.50 192.50 6,597
8th Sep 2025 (Mon) 197.50 197.50 195.00 195.00 10,378
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
3rd Mar 2025 12:05 pm RNS FDA Grants Orphan Drug Designation
28th Feb 2025 12:00 pm RNS Notice of Annual General Meeting
27th Feb 2025 7:30 am RNS Positive EMA Opinion on Orphan Drug Designation
27th Feb 2025 7:15 am RNS Annual Report 2024 published
27th Feb 2025 7:00 am RNS Financial Statement 1 January to 31 December 2024
19th Feb 2025 10:00 am RNS Notice of Financial Statement and Annual Report
14th Feb 2025 12:00 pm RNS Holding(s) in Company
11th Feb 2025 7:30 am RNS Change of Broker
6th Feb 2025 3:00 pm RNS Holding(s) in Company
6th Feb 2025 7:00 am RNS Results of Oversubscribed Placing
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

Faron Pharmaceuticals narrows loss as cancer treatment trials continue

27th Aug 2025 10:25

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday posted an improvement in half-year results with "strong and steady progress" for its immunotherapy programme. Read More

UK earnings, trading statements calendar - next 7 days

20th Aug 2025 12:20

Read More

Faron advances development of cancer immunotherapy after FDA feedback

18th Aug 2025 09:10

(Alliance News) - Faron Pharmaceuticals Ltd on Monday outlined its plans to further progress its study of an investigational cancer immunotherapy, after receiving positive and "valuable" feedback from the US Food & Drug Administration. Read More

LONDON MARKET OPEN: Stocks up with eyes on Powell at Jackson Hole

18th Aug 2025 08:54

(Alliance News) - Stock prices in London opened higher on Monday, as investors digest last week's meeting between Donald Trump and Vladimir Putin, and look to the Jackson Hole symposium and key data releases later in the week. Read More

Faron Pharma hails therapy data on blood cancer ahead of FDA meeting

6th Aug 2025 14:32

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday announced data for its investigational immunotherapy bexmarilimab, ahead of an upcoming meeting with the US Food & Drug Administration. Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value9,483.58
Change4.44

Login to your account

Forgot Password?

Not Registered